CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
Cardiovascular disease
Chronic kidney disease
Diabetes
GIP/GLP-1 receptor agonist
Heart failure
Obesity
SGLT2 inhibitor
Journal
Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637
Informations de publication
Date de publication:
16 03 2023
16 03 2023
Historique:
received:
07
02
2023
accepted:
02
03
2023
entrez:
17
3
2023
pubmed:
18
3
2023
medline:
21
3
2023
Statut:
epublish
Résumé
The 8th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Kidney, and Glycemic Outcomes was held virtually on November 10-12, 2022. Following the tradition of previous summits, this reference congress served as a platform for in-depth discussion and exchange on recently completed outcomes trials as well as key trials important to the cardiovascular (CV) field. This year's focus was on the results of the DELIVER, EMPA-KIDNEY and SURMOUNT-1 trials and their implications for the treatment of heart failure (HF) and chronic kidney disease (CKD) with sodium-glucose cotransporter-2 (SGLT2) inhibitors and obesity with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. A broad audience of primary care physicians, diabetologists, endocrinologists, cardiologists, and nephrologists participated online in discussions on new consensus recommendations and guideline updates on type 2 diabetes (T2D) and CKD management, overcoming clinical inertia, glycemic markers, continuous glucose monitoring (CGM), novel insulin preparations, combination therapy, and reclassification of T2D. The impact of cardiovascular outcomes on the design of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) trials, as well as the impact of real-world evidence (RWE) studies on the confirmation of CVOT outcomes and clinical trial design, were also intensively discussed. The 9th Cardiovascular Outcome Trial Summit will be held virtually on November 23-24, 2023 ( http://www.cvot.org ).
Identifiants
pubmed: 36927451
doi: 10.1186/s12933-023-01788-6
pii: 10.1186/s12933-023-01788-6
pmc: PMC10019427
doi:
Substances chimiques
Blood Glucose
0
Glucagon-Like Peptide-1 Receptor
0
Hypoglycemic Agents
0
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
59Informations de copyright
© 2023. The Author(s).
Références
N Engl J Med. 2021 Aug 5;385(6):503-515
pubmed: 34170647
Diabetes Obes Metab. 2022 Dec;24(12):2364-2372
pubmed: 36053820
Diabetes Obes Metab. 2016 Mar;18(3):203-16
pubmed: 26489970
J Hepatol. 2019 Oct;71(4):793-801
pubmed: 31279902
Cardiovasc Diabetol. 2019 Mar 11;18(1):30
pubmed: 30857522
Clin Res Cardiol. 2021 Jul;110(7):921-937
pubmed: 32696080
JAMA. 2021 Jun 8;325(22):2262-2272
pubmed: 34077499
Cureus. 2022 Apr 1;14(4):e23731
pubmed: 35509734
N Engl J Med. 2022 May 5;386(18):1680-1682
pubmed: 35485775
Diabetes Care. 2022 Jul 7;45(7):1592-1600
pubmed: 35671039
Cardiovasc Diabetol. 2016 Feb 18;15:33
pubmed: 26892706
N Engl J Med. 2013 Oct 3;369(14):1327-35
pubmed: 23992602
N Engl J Med. 2019 Jan 24;380(4):347-357
pubmed: 30415602
N Engl J Med. 2021 Jun 10;384(23):2219-2228
pubmed: 34107181
Circulation. 2017 Jul 18;136(3):249-259
pubmed: 28522450
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Pulm Pharmacol Ther. 2014 Apr;27(2):129-38
pubmed: 24468677
Lancet. 2018 Oct 27;392(10157):1519-1529
pubmed: 30291013
Diabetes Technol Ther. 2022 May;24(5):324-331
pubmed: 34962151
Kidney Int. 2017 Aug;92(2):388-396
pubmed: 28577854
Ann Intern Med. 2022 Aug;175(8):1154-1160
pubmed: 35785533
Nephrol Dial Transplant. 2023 Aug 31;38(9):2041-2051
pubmed: 36651820
Lancet. 2022 Jan 22;399(10322):394-405
pubmed: 34600604
BMJ. 2021 May 11;373:n1091
pubmed: 33975892
N Engl J Med. 2016 Nov 10;375(19):1834-1844
pubmed: 27633186
Diabetes Care. 2022 Jul 7;45(7):1670-1690
pubmed: 35796765
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
N Engl J Med. 2013 Oct 3;369(14):1317-26
pubmed: 23992601
Diabetologia. 2022 Dec;65(12):1925-1966
pubmed: 36151309
Diabetes Care. 2019 Mar;42(3):416-426
pubmed: 30104301
Clin Kidney J. 2021 Apr 11;14(6):1570-1578
pubmed: 34249352
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045
pubmed: 28522654
Endocr Pract. 2021 May;27(5):449-454
pubmed: 33853718
Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694
pubmed: 31345776
N Engl J Med. 2023 Jan 12;388(2):117-127
pubmed: 36331190
N Engl J Med. 2022 Jul 21;387(3):205-216
pubmed: 35658024
Cardiovasc Diabetol. 2017 Mar 11;16(1):35
pubmed: 28284218
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Kidney Int. 2022 Nov;102(5S):S1-S127
pubmed: 36272764
Cardiovasc Diabetol. 2018 Feb 19;17(1):30
pubmed: 29458368
Cardiovasc Diabetol. 2022 Apr 8;21(1):50
pubmed: 35395808
Am Heart J. 2023 Feb;256:2-12
pubmed: 36279931
JAMA. 2019 Jan 1;321(1):69-79
pubmed: 30418475
Diabetes Care. 2022 Jul 7;45(7):1621-1630
pubmed: 35607770
Diabetes Res Clin Pract. 2020 Apr;162:108092
pubmed: 32109519
Clin Diabetes. 2016 Oct;34(4):173-180
pubmed: 27766008
Cardiovasc Diabetol. 2018 Jun 8;17(1):83
pubmed: 29884191
Lancet. 2019 Jul 13;394(10193):121-130
pubmed: 31189511
Diabetes Res Clin Pract. 2022 Jan;183:109119
pubmed: 34879977
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
Cardiovasc Diabetol. 2020 Apr 17;19(1):47
pubmed: 32303223
BMJ. 2021 Jan 13;372:m4573
pubmed: 33441402
N Engl J Med. 2021 Dec 9;385(24):2252-2263
pubmed: 34449181
Diabetes Care. 2022 Jan 1;45(Suppl 1):S97-S112
pubmed: 34964871
N Engl J Med. 2020 Oct 8;383(15):1425-1435
pubmed: 32966714
N Engl J Med. 2016 Jul 28;375(4):311-22
pubmed: 27295427
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369
pubmed: 29503172
N Engl J Med. 2021 Jan 14;384(2):129-139
pubmed: 33200891
N Engl J Med. 2015 Dec 3;373(23):2247-57
pubmed: 26630143
Nat Med. 2021 Jan;27(1):49-57
pubmed: 33398163
JAMA. 2019 Sep 24;322(12):1155-1166
pubmed: 31536101
N Engl J Med. 2017 Sep 28;377(13):1228-1239
pubmed: 28910237
Cardiovasc Diabetol. 2021 Mar 31;20(1):75
pubmed: 33789663
N Engl J Med. 2022 Sep 22;387(12):1089-1098
pubmed: 36027570
Lancet. 2010 Jun 26;375(9733):2215-22
pubmed: 20609967
N Engl J Med. 2015 Jul 16;373(3):232-42
pubmed: 26052984
Diabetes Educ. 2020 Aug;46(4):323-334
pubmed: 32780003
Clin Pharmacol Ther. 2019 Jul;106(1):36-39
pubmed: 30970161
J Diabetes Sci Technol. 2022 Jan;16(1):3-6
pubmed: 34711063
Diabetes Care. 2022 Dec 1;45(12):3075-3090
pubmed: 36189689
N Engl J Med. 2021 Sep 2;385(10):896-907
pubmed: 34215025
JAMA Netw Open. 2022 Feb 1;5(2):e2148030
pubmed: 35175345
Ther Adv Endocrinol Metab. 2022 Jul 19;13:20420188221112490
pubmed: 35874312
Circulation. 2022 Feb 22;145(8):565-574
pubmed: 34775781
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
J Am Coll Cardiol. 2018 Jun 5;71(22):2497-2506
pubmed: 29852973
Diabetologia. 2022 Jan;65(1):206-215
pubmed: 34676424